TO KNOW THE EFFECT OF BUTORPHANOL WITH LEVOBUPIVACAINE IN LOWERE LIMB SURGERIES

EFFICACY OF BUTORPHANOL AS AN ADJUVANT TO INTRATHECAL LEVOBUPIVACAINE IN LOWER LIMB SURGERIES - RANDOMIZED CONTROLLED TRAIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/04/051754

Enrollment

Registered

2023-04-19

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: BUTORPHANOL ADJUVANT WITH LEVOBUPIVACAINE IN SUBARACHNOID BLOCK: 3.8 ML OF DRUG INTRATHECALLY 1 year Control Intervention1: SUBARACHNOID ANAESTHESIA: 3.8 ML OF DRUG INTRATHECALLY 1 year

Eligibility

Inclusion criteria

Inclusion criteria: 1. PATIENT AGED 18 YEARS AND ABOVE 2. AMERICAN SOCIETY OF ANAESTHESIOLOGISTS (ASA) PHYSICAL STATUS I,II 3. PATIENT UNDERGOING LOWER LIMB SURGERIES UNDER SPINAL ANAESTHESIA

Exclusion criteria

Exclusion criteria: 1. H/O ALLERGY TO THE DRUGS TO BE USED (LEVOBUPIVACAINE AND/OR BUTORPHANOL) 2. PATIENT ON PAIN MODULATION THERAPY 3. COMPLEX REGIONAL PAIN SYNDROME 4. PSYCHIATRIC ILLNESS 5. ADDICTION TO ALCOHOL / OPIODS

Design outcomes

Primary

Measure	Time frame
1. FIRST RESCUE ANALGESIC REQUIREMENT 2. VISUAL ANALOGUE SCORETimepoint: FIRST POST OPERATIVE DAY	—

Secondary

Measure	Time frame
1. TIME REQUIRED TO REGAIN GRADE V MUSCLE POWER IN QUADRICEPS MUSCLE 2. INTRAOPERATIVE HYPOTENSIONTimepoint: FIRST POST OPERATIVE DAY	—

Countries

India

Contacts

Public ContactAJP UTKALIKA

KALINGA INSTITUTE OF MEDICAL SCIENCES

lingaraj.sahu@kims.ac.in8280166501

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026